Cargando…

SARS-CoV-2 potential drugs, drug targets, and biomarkers: a viral-host interaction network-based analysis

COVID-19 is a global pandemic impacting the daily living of millions. As variants of the virus evolve, a complete comprehension of the disease and drug targets becomes a decisive duty. The Omicron variant, for example, has a notably high transmission rate verified in 155 countries. We performed inte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samy, Asmaa, Maher, Mohamed A., Abdelsalam, Nehal Adel, Badr, Eman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279364/ https://www.ncbi.nlm.nih.gov/pubmed/35831333 http://dx.doi.org/10.1038/s41598-022-15898-w

Ejemplares similares

Executable network of SARS-CoV-2-host interaction predicts drug combination treatments
por: Howell, Rowan, et al.
Publicado: (2022)

Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2
por: Chen, Na, et al.
Publicado: (2022)

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
por: Liu, Xiaonan, et al.
Publicado: (2021)

The consequences of viral infection on host DNA damage response: a focus on SARS-CoVs
por: Mekawy, Asmaa S., et al.
Publicado: (2022)

Promising anti-SARS-CoV-2 drugs by effective dual targeting against the viral and host proteases
por: Elseginy, Samia A., et al.
Publicado: (2021)

Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
por: Sadegh, Sepideh, et al.
Publicado: (2020)

Urinary biomarkers for early detection of platinum based drugs induced nephrotoxicity
por: Abdelsalam, Mostafa, et al.
Publicado: (2018)

Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions
por: Butler, Daniel, et al.
Publicado: (2021)

Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs
por: Eskandarzade, Neda, et al.
Publicado: (2022)

Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis
por: Sardar, Rahila, et al.
Publicado: (2020)

Integrative In Silico Investigation Reveals the Host-Virus Interactions in Repurposed Drugs Against SARS-CoV-2
por: Yu, Wenhui, et al.
Publicado: (2022)

Immune‐viral dynamics modeling for SARS‐CoV‐2 drug development
por: Cao, Youfang, et al.
Publicado: (2021)

The “Invisible Enemy” SARS-CoV-2: Viral Spread and Drug Treatment
por: Tanase, Alina, et al.
Publicado: (2022)

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
por: Girgis, Adel S., et al.
Publicado: (2023)

Host microRNA interactions with the SARS-CoV-2 viral genome 3’-untranslated region
por: Frye, Caleb J., et al.
Publicado: (2023)

Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications
por: Agarwal, Shubham, et al.
Publicado: (2020)

Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction
por: Westmark, Cara J., et al.
Publicado: (2020)

Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2
por: Bekheit, Mohamed S., et al.
Publicado: (2023)

Network-based virus-host interaction prediction with application to SARS-CoV-2
por: Du, Hangyu, et al.
Publicado: (2021)

Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing
por: Mosharaf, Md. Parvez, et al.
Publicado: (2022)

Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions
por: Ehrlich, Haley, et al.
Publicado: (2021)

Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures
por: Peng, Lihong, et al.
Publicado: (2021)

Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
por: Zhang, Shaojun, et al.
Publicado: (2021)

Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties
por: Rosenbloom, Daniel Scholes, et al.
Publicado: (2020)

A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2
por: Kivrak, Arif, et al.
Publicado: (2021)

The global succinylation of SARS-CoV-2–infected host cells reveals drug targets
por: Liu, Quan, et al.
Publicado: (2022)

Fighting on two fronts: drug–drug interactions in people living with HIV infected with SARS-CoV-2
por: Bahap, Melda, et al.
Publicado: (2021)

Principles and Terminology for Host–Microbiome–Drug Interactions
por: Heirali, Alya, et al.
Publicado: (2023)

Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2021)

Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions
por: Crescioli, Giada, et al.
Publicado: (2020)

Viral and Host Genetic and Epigenetic Biomarkers Related to SARS-CoV-2 Cell Entry, Infection Rate, and Disease Severity
por: Gaspersic, Jernej, et al.
Publicado: (2022)

Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus–Host Interactome
por: Fang, Jiansong, et al.
Publicado: (2021)

Systematic discovery and functional interrogation of SARS-CoV-2 viral RNA-host protein interactions during infection
por: Flynn, Ryan A., et al.
Publicado: (2020)

Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication
por: Yang, Zemin, et al.
Publicado: (2023)

Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
por: Calligari, Paolo, et al.
Publicado: (2020)

Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor
por: Ahsan, Tamim, et al.
Publicado: (2021)

Systems virology: host-directed approaches to viral pathogenesis and drug targeting
por: Law, G. Lynn, et al.
Publicado: (2013)

An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors
por: Trezza, Alfonso, et al.
Publicado: (2020)

Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection
por: Bhatti, Jasvinder Singh, et al.
Publicado: (2020)

Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro
por: Salas Rojas, Mónica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7p9dans8580fo4mi3842v7vtor